跳至主要内容
临床试验/IRCT20090117001556N125
IRCT20090117001556N125尚未招募2 期

Studying the effects of Celecoxib as monotherapy in the treatment of postpartum depression with mild intensity to the average: response to treatment of Celecoxib by area Brain-Derived Neurotrophic Factor (BDNF) and inflammatory cytokines (TNFa, IFN? , IL-1?, IL-1? IL-6, IL-8)

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Age between 18 to 45
  • Having mild to moderate depression according to Hamilton Depression Rating Scale (HAM-D)

排除标准

  • Having severe depression according to Hamilton Depression Rating Scale (HAM-D or HDRS)
  • Addiction to drugs
  • Addiction to alcohol
  • Presence of Thyroid disease
  • Receiving any antidepressant medications during past one month prior to the trial
  • Receiving Electroconvulsive therapy during past two months prior to the trial
  • Any other diagnosis according to axis-1, DSM-5
  • Having a risk of suicide based on doctor's clinical judgement or having a score of >2 in suicide item of Hamilton Depression Rating Scale (HAM-D or HDRS)
  • Concomitant use of medications that increase the risk of gastrointestinal bleeding
  • Presence of cardiovascular disease
  • Pregnant and lactating women
  • Risk of child murder

研究者

相似试验